Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Barsouk

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Hepatic Medicine : Evidence and Research|January 15, 2021
Chemical Risk Factors of Primary Liver Cancer: An UpdateAdam Barsouk, Krishna Chaitanya Thandra, Kalyan Saginala, et al.
Medical Sciences (Basel, Switzerland)|March 24, 2022
US Cancer Screening Recommendations: Developments and the Impact of COVID-19Adam Barsouk, Kalyan Saginala, John Sukumar Aluru, et al.
Medical Sciences (Basel, Switzerland)|October 26, 2021
Epidemiology of MelanomaKalyan Saginala, Adam Barsouk, John Sukumar Aluru, et al.
European Thyroid Journal|November 1, 2024
Real world outcomes of cabozantinib therapy in poorly differentiated thyroid carcinomaOmar Elghawy, Adam Barsouk, Jessica Xu, et al.
Medical Sciences (Basel, Switzerland)|September 29, 2019
Targeted Therapies and Immunotherapies in the Treatment of Esophageal CancersAdam Barsouk, Prashanth Rawla, Andreas V Hadjinicolaou, et al.
Contemporary Oncology (Poznan, Poland)|April 29, 2021
Epidemiology of lung cancerKrishna Chaitanya Thandra, Adam Barsouk, Kalyan Saginala, et al.
Medical Sciences (Basel, Switzerland)|March 19, 2020
Epidemiology of Bladder CancerKalyan Saginala, Adam Barsouk, John Sukumar Aluru, et al.
Clinical and Experimental Hepatology|January 29, 2021
Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progressionKrishna Chaitanya Thandra, Adam Barsouk, Kalyan Saginala, et al.
Cancers|October 16, 2024
Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma TreatmentAdam Barsouk, Omar Elghawy, Austin Yang, et al.
Journal of the Endocrine Society|September 19, 2024
Single-Institution Experience of Larotrectinib Therapy for Patients With <i>NTRK</i> Fusion-Positive Thyroid CarcinomaOmar Elghawy, Adam Barsouk, Alec Heidlauf, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Hepatic Medicine : Evidence and Research|January 15, 2021
Chemical Risk Factors of Primary Liver Cancer: An UpdateAdam Barsouk, Krishna Chaitanya Thandra, Kalyan Saginala, et al.
Medical Sciences (Basel, Switzerland)|March 24, 2022
US Cancer Screening Recommendations: Developments and the Impact of COVID-19Adam Barsouk, Kalyan Saginala, John Sukumar Aluru, et al.
Medical Sciences (Basel, Switzerland)|October 26, 2021
Epidemiology of MelanomaKalyan Saginala, Adam Barsouk, John Sukumar Aluru, et al.
European Thyroid Journal|November 1, 2024
Real world outcomes of cabozantinib therapy in poorly differentiated thyroid carcinomaOmar Elghawy, Adam Barsouk, Jessica Xu, et al.
Medical Sciences (Basel, Switzerland)|September 29, 2019
Targeted Therapies and Immunotherapies in the Treatment of Esophageal CancersAdam Barsouk, Prashanth Rawla, Andreas V Hadjinicolaou, et al.
Contemporary Oncology (Poznan, Poland)|April 29, 2021
Epidemiology of lung cancerKrishna Chaitanya Thandra, Adam Barsouk, Kalyan Saginala, et al.
Medical Sciences (Basel, Switzerland)|March 19, 2020
Epidemiology of Bladder CancerKalyan Saginala, Adam Barsouk, John Sukumar Aluru, et al.
Clinical and Experimental Hepatology|January 29, 2021
Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progressionKrishna Chaitanya Thandra, Adam Barsouk, Kalyan Saginala, et al.
Cancers|October 16, 2024
Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma TreatmentAdam Barsouk, Omar Elghawy, Austin Yang, et al.
Journal of the Endocrine Society|September 19, 2024
Single-Institution Experience of Larotrectinib Therapy for Patients With <i>NTRK</i> Fusion-Positive Thyroid CarcinomaOmar Elghawy, Adam Barsouk, Alec Heidlauf, et al.
Pageof 4